Edgewood Management Portfolio holdings
AUM
$31.5B
This Quarter Return
-7.03%
1 Year Return
+19.46%
3 Year Return
+128.01%
5 Year Return
+144.65%
10 Year Return
+626.11%
AUM
$28.7B
AUM Growth
+$28.7B
(-15%)
Cap. Flow
-$2.03B
Cap. Flow
% of AUM
-7.06%
Top 10 Holdings %
Top 10 Hldgs %
55.55%
Holding
81
New
4
Increased
10
Reduced
25
Closed
1
Top Buys
| 1 |
Blackstone
BX
|
$299M |
| 2 |
Netflix
NFLX
|
$230M |
| 3 |
NVIDIA
NVDA
|
$195M |
| 4 |
Match Group
MTCH
|
$137M |
| 5 |
Nike
NKE
|
$49.5M |
Top Sells
| 1 |
Snap
SNAP
|
$728M |
| 2 |
Visa
V
|
$368M |
| 3 |
Microsoft
MSFT
|
$280M |
| 4 |
S&P Global
SPGI
|
$239M |
| 5 |
Chipotle Mexican Grill
CMG
|
$162M |
Sector Composition
| 1 | Technology | 30.17% |
| 2 | Healthcare | 19.16% |
| 3 | Financials | 18.72% |
| 4 | Consumer Discretionary | 13.64% |
| 5 | Communication Services | 8.05% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
LAC
51
DELISTED
Lithium Americas Corp. Common Shares
LAC
| $918K | ﹤0.01% | 35,000 | – | – |
|
52
Exxon Mobil
XOM
$487B
| $852K | ﹤0.01% | 9,761 | – | – |
|
53
Agios Pharmaceuticals
AGIO
$2.19B
| $848K | ﹤0.01% | +30,000 | New | +$848K |
|
54
Palantir
PLTR
$372B
| $813K | ﹤0.01% | +100,000 | New | +$813K |
|
55
Merck
MRK
$210B
| $673K | ﹤0.01% | 7,818 | – | – |
|
56
Zoetis
ZTS
$69.3B
| $659K | ﹤0.01% | 4,442 +389 | +10% | +$57.7K |
|
57
Seres Therapeutics
MCRB
$166M
| $642K | ﹤0.01% | +100,000 | New | +$642K |
|
|
58
Snap
SNAP
$12.1B
| $641K | ﹤0.01% | 65,293 -74,200,422 | -100% | -$728M |
|
59
Arrowhead Research
ARWR
$3.05B
| $628K | ﹤0.01% | 19,000 | – | – |
|
60
Vodafone
VOD
$28.8B
| $599K | ﹤0.01% | 52,886 | – | – |
|
61
Charles Schwab
SCHW
$174B
| $572K | ﹤0.01% | 7,960 | – | – |
|
62
Ecolab
ECL
$78.6B
| $537K | ﹤0.01% | 3,719 | – | – |
|
63
Duke Energy
DUK
$95.3B
| $509K | ﹤0.01% | 5,468 | – | – |
|
64
Tesla
TSLA
$1.08T
| $484K | ﹤0.01% | 1,824 +1,216 | +200% | +$323K |
|
|
ETG
65
Eaton Vance Tax-Advantaged Global Dividend Income Fund
ETG
$1.59B
| $483K | ﹤0.01% | 32,000 | – | – |
|
66
Ginkgo Bioworks
DNA
$750M
| $468K | ﹤0.01% | 150,000 +50,000 | +50% | +$156K |
|
67
AT&T
T
$209B
| $453K | ﹤0.01% | 29,500 | – | – |
|
68
BlackRock New York Municipal Income Trust
BNY
$231M
| $440K | ﹤0.01% | 45,000 +10,000 | +29% | +$97.8K |
|
69
Armata Pharmaceuticals
ARMP
$90.6M
| $422K | ﹤0.01% | 100,000 | – | – |
|
70
Freeport-McMoran
FCX
$63.7B
| $391K | ﹤0.01% | 14,319 | – | – |
|
|
SPLK
71
DELISTED
Splunk Inc
SPLK
| $376K | ﹤0.01% | 5,000 | – | – |
|
72
Warner Bros
WBD
$28.8B
| $353K | ﹤0.01% | 30,725 +18,638 | +154% | +$214K |
|
73
Verizon
VZ
$186B
| $327K | ﹤0.01% | 8,616 | – | – |
|
74
Stryker
SYK
$150B
| $324K | ﹤0.01% | 1,600 | – | – |
|
75
Procter & Gamble
PG
$368B
| $278K | ﹤0.01% | 2,200 | – | – |
|